From patient samples to medical discoveries: LIH biobank earns top international accreditation

• Integrated Biobank of Luxembourg (IBBL)
• Quality & Safety Management office (QSMO)
• Translational Medicine Operations Hub (TMOH)

Following a 3.5-day audit in January, the Luxembourg Institute of Health (LIH) has been recognised with ISO 20387 accreditation for its biobanking activities by the UK accreditation body (UKAS).

Behind many medical breakthroughs lies a crucial, often unmentioned resource: high-quality patient samples. At the Luxembourg Institute of Health (LIH), these samples are carefully processed and preserved in its Integrated Biobank of Luxembourg (IBBL) where they form the basis for translational research, enabling better diagnosis, prevention and treatment strategies.

This work has now received international recognition. Following a 3.5 day audit in January, the LIH has been granted ISO 20387:2018 accreditation for biobanking activities by the UK Accreditation Service (UKAS), confirming that its technical competence meets the highest quality standards.

Beyond the accreditation, the achievement shows that Luxembourg has built a fully integrated ecosystem to support biomedical research.

A “treasure trove” for future medicine

At the heart of this effort is the IBBL, where biological samples such as blood, DNA, or immune cells are transformed into long-term scientific assets. Each sample represents more than just data – it is a snapshot of human health and disease, and a potential key to future discoveries.

“Biobanked samples are a true treasure trove for translational research,” said Dr Claire Barbieux, Head of the IBBL.

When collected and processed at the highest quality standards, they allow researchers to uncover disease mechanisms, identify biomarkers, and ultimately develop more precise and effective treatments.

Today, the IBBL stores over 2,2 millions samples and collaborates with partners worldwide, supporting a wide range of research projects and disease areas.

A unique breadth of services in Europe

The accreditation covers the full journey of a blood sample: from collection and processing to testing and long-term storage.

The IBBL stands out as one of the few biobank in Europe offering such a comprehensive breadth of accredited services, encompassing for example a multitude of blood-derived materials and advanced processing techniques. This end-to-end capability ensures that researchers can rely on consistent, high-quality samples tailored for diverse scientific needs.

The Certificate and Schedule of Accreditation issued by UKAS are available in the LIH website.

A collective effort across LIH

This milestone reflects not just the work of one unit, but a coordinated effort across the Translational Medicine Operations Hub (TMOH), a unique structure bringing together clinical operations, biobanking, data management and quality systems.

From sample collection to data integration and storage, teams across the LIH such as the Clinical Project Management Office (CPMO), the Clinical and Epidemiological Investigation Center (CIEC), the Department of Medical Informatics (DMI), and the Quality Management Office (QMO) contribute to a seamless pipeline.

“This accreditation highlights the strength of our integrated approach,” said Dr Hermann Thien, Director of the TMOH. “By connecting clinical research, biobanking and data expertise, we ensure that every sample collected today can generate meaningful insights for tomorrow’s patients.”

Enabling the future of personalised medicine

High-quality biobanking is a cornerstone of modern biomedical research, particularly in areas such as personalised medicine, where understanding individual variability is key.

With this accreditation, complementing its long-standing ISO 9001 certification and ISO 17025 accreditation, the LIH reinforces its position as a trusted partner for national and international research initiatives. It shows that Luxembourg has built a robust, forward-looking infrastructure where patient contributions, carefully preserved today, can drive the discoveries that improve healthcare tomorrow.